As we wrap up Q1 2026, two themes continue to dominate conversations across financial services: private credit and AI. Both are evolving rapidly and increasingly intersecting.
Receiving multiple job offers is an exciting position to be in, but it also comes with a unique challenge: how do you decide which opportunity is truly the best for you?
Does this sound familiar? You hire top talent, yet employees continue to resign, or candidates frequently drop out during the interview process. High turnover and repeated losses of strong talent aren’t just frustrating; they often point to deeper challenges within your organization.
Hiring decisions are rarely easy. Even when a standout candidate comes along who performs well throughout the interview process, many hiring managers feel indecision over the fact that there could be someone out there better suited for the role.
By now, most firms have experimented with AI in some form. Some have rolled out enterprise tools. Others are testing point solutions. A few have tried to embed AI into core workflows. But for many, the results have been underwhelming.
Many life sciences companies — including biotech, pharmaceutical, and medical device organizations — face similar operational challenges as they move from clinical-stage development toward commercialization.
